PABYX
Price
$16.12
Change
+$0.10 (+0.62%)
Updated
Dec 24 closing price
RLBCX
Price
$34.57
Change
+$0.23 (+0.67%)
Updated
Dec 24 closing price
Ad is loading...

PABYX vs RLBCX

Header iconPABYX vs RLBCX Comparison
Open Charts PABYX vs RLBCXBanner chart's image
Putnam Dynamic Asset Allocation Bal Y
Price$16.12
Change+$0.10 (+0.62%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R3
Price$34.57
Change+$0.23 (+0.67%)
VolumeN/A
CapitalizationN/A
PABYX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABYX vs. RLBCX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABYX is a StrongBuy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 238B vs. PABYX (2.13B). RLBCX pays higher dividends than PABYX: RLBCX (1.98) vs PABYX (1.84). PABYX was incepted earlier than RLBCX: PABYX (30 years) vs RLBCX (23 years). PABYX is a more actively managed with annual turnover of: 302.00 vs. RLBCX (171.00). PABYX has a lower initial minimum investment than RLBCX: PABYX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 11.06 vs. PABYX (8.67). RLBCX return over 5 years is better than : 29.35 vs. PABYX (16.67).
PABYXRLBCXPABYX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD8.24510.60978%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.13B238B1%
Annual Yield % from dividends1.841.9893%
Returns for 1 year8.6711.0678%
Returns for 3 years2.039.0322%
Returns for 5 years16.6729.3557%
Returns for 10 years30.4550.4460%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWH0.770.02
+3.11%
Aspira Women's Health
FWRG19.280.40
+2.12%
First Watch Restaurant Group
WAB194.162.71
+1.42%
Wabtec
TXG14.67-0.06
-0.41%
10x Genomics
LXRX0.76-0.07
-8.37%
Lexicon Pharmaceuticals